Abstract: Disclosed are compounds of Formula (I) N-oxides, or salts thereof, wherein G, A, R1, R5, and n are defined herein. Also disclosed are methods of using such compounds as inhibitors of signaling through Toll-like receptor 7, or 8, or 9, and pharmaceutical compositions comprising such compounds. These compounds are useful in treating inflammatory and autoimmune diseases.

Abstract: Accurate, unambiguous, and space-efficient electronic display techniques are provided for presenting the operator with an indicator whose graphical configuration varies in accordance with whether the relevant control value is within a predetermined tolerance range of a set-point value. More particularly, a control value indicator includes a scale having an axis associated with the control value, a set-point marker placed at a first position along the scale for indicating the set-point value, and a pointer having a second position along the scale for indicating the control value. The pointer and/or the set-point marker exhibit a first graphical configuration corresponding to the case where the control value is not within the predetermined tolerance of the set-point value, and a second graphical configuration corresponding to the case where the control value is within the predetermined tolerance of the set-point value.

Abstract: Aircraft/engine performance is determined by the method of the present invention, wherein the performance characteristics are defined by learned performance parameters. The method includes the steps of learning the performance parameters of the aircraft/engine combination, for a given flight, using previously learned performance parameters and current observations. Then, based on the performance parameters learned from the learning step, a prediction is made of the performance of the aircraft/engine combination for subsequent flights.